Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Endobronchial Silicone Valve for Patients With Emphysema

NCT: NCT07097896 · RECRUITING

NCT IDNCT07097896
StatusRECRUITING
Start Date2025-07-08
Completion2027-07
SponsorChina-Japan Friendship Hospital (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research is to evaluate the efficacy and safety of endobronchial silicone valve in patients with severe emphysema.

Frequently Asked Questions

What is Endobronchial Silicone Valve for Patients With Emphysema?

Endobronchial Silicone Valve for Patients With Emphysema is a clinical trial registered under NCT07097896. Current status: RECRUITING.

What is the status of NCT07097896?

The current status of NCT07097896 (Endobronchial Silicone Valve for Patients With Emphysema) is: RECRUITING.

When did Endobronchial Silicone Valve for Patients With Emphysema start?

Endobronchial Silicone Valve for Patients With Emphysema started on 2025-07-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑